Fresenius Medical Care share buyback
Analysis based on 29 articles · First reported Jun 01, 2026 · Last updated Sep 21, 2026
The ongoing share buyback supports Fresenius Medical Care's stock price by reducing the number of outstanding shares and signaling management's confidence. The consistent repurchases at prices around 40 euros may provide a floor for the stock, though the overall market sentiment remains neutral to slightly positive.
Fresenius Medical Care AG is conducting a share buyback program in multiple tranches. The first tranche, disclosed on May 28, 2026, has seen purchases of 155,000 shares in late May, 441,000 shares in early June, and 6,589,405 shares by late August. The second tranche, disclosed on January 12, 2026, has acquired 3,535,040 shares as of late July. The buybacks are executed by a commissioned credit institution on venues such as XETR and CEUX, with weighted average prices ranging from approximately 36.99 to 43.04 euros. The company provides regular interim reports on the progress of the buyback.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard